The estimated Net Worth of Jonathan P. Di Vincenzo is at least $847 Mille dollars as of 27 March 2024. Jonathan Vincenzo owns over 3,012 units of Revvity stock worth over $739,239 and over the last 11 years Jonathan sold PKI stock worth over $107,745.
Jonathan has made over 6 trades of the Revvity stock since 2023, according to the Form 4 filled with the SEC. Most recently Jonathan exercised 3,012 units of PKI stock worth $347,253 on 27 March 2024.
The largest trade Jonathan's ever made was exercising 3,012 units of Revvity stock on 27 March 2024 worth over $347,253. On average, Jonathan trades about 337 units every 8 days since 2013. As of 27 March 2024 Jonathan still owns at least 6,412 units of Revvity stock.
You can see the complete history of Jonathan Vincenzo stock trades at the bottom of the page.
Jonathan's mailing address filed with the SEC is 531, South Spring Street, Burlington, Alamance County, North Carolina, 27215, United States.
Over the last 26 years, insiders at Revvity have traded over $204,298,889 worth of Revvity stock and bought 55,200 units worth $1,110,570 . The most active insiders traders include Alexis P Michas, Gregory L Summe e Robert F Friel. On average, Revvity executives and independent directors trade stock every 25 days with the average trade being worth of $6,184,617. The most recent stock trade was executed by Andrew Okun on 13 April 2023, trading 2,435 units of PKI stock currently worth $332,402.
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.
Revvity executives and other stock owners filed with the SEC include: